Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“My thanks to OncoDaily for organising and choosing sarcomas as the topic for the first OncoDaily Grand Rounds on the sidelines of ASCO26 in Chicago this year.
Happy to share my lecture on Antibody Drug Conjugates as a new treatment modality in sarcomas.”
How Close Are We to a Cure? ADCs in Sarcoma Treatment | Dr. Herbert Loong
You can also read:
OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition Brought Global Experts Together in Chicago
